OmegaBio conducted the survey of Australian biotechnology organisations in April and May 2003, polling public companies, private companies and university, CSIRO and other research institutions to determine their present and future usage of IT.
The survey found that most companies had a variety of computer hardware deployed in the organisation, with most having IBM-compatible computers and a quarter sporting Apple Macs. Many also had Unix workstations, mostly Sun or SGI.
Toshiba is the most common laptop deployed throughout the biotech organisations - if you count HP and Compaq separately - but Dell is expected to be the most common desktop and laptop supplier within 12 months. When asked about their preferred vendors, the Dell was cited the most for desktops and laptops, Toshiba led the pack for PDA's and mobile devices and HP was the most chosen to supply servers.
Nearly half of the organisations surveyed said they planned to buy storage hardware in the next 12 months, and the average IT budget of AU$4,287 per employee was expected to grow by around 10 percent in the next year.
However, the main problem facing most biotech organisations was a lack of money, followed by problems with data analysis, personnel and training problems and frustration with poor products.
No Way!
Dell is dreaming too big for nothing. Whoever thinks that Apple is out of question in near future, is foolish. Motorola is the reason why Apple is not wining in a big way in corporates. Just wait untill Apple starts using IBM PowerPC 970 in the middle of 2003 and then the Power5 in next year both based on 32-bit and 64-bit like AMD's opteron then we can talk.